{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:13:54Z","timestamp":1770218034269,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T00:00:00Z","timestamp":1408492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"ARMIA (Associazione Ricerca Malattie Immunologiche Allergiche)"},{"name":"CNR Project \u2018FaReBio di Qualita\u2019"},{"name":"MIUR Project PON","award":["01 02388"],"award-info":[{"award-number":["01 02388"]}]},{"name":"Novartis Pharmaceuticals"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.imlet.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T06:00:19Z","timestamp":1409896819000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"PA","title":["Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients"],"prefix":"10.1016","volume":"162","author":[{"given":"Pierluigi","family":"Mauri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Di Silvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Benazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Walter Dal","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Holgate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2014.08.010_bib0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMcp1214826","article-title":"Clinical practice. Mild asthma","volume":"369","author":"Bel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.08.010_bib0010","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(06)69288-X","article-title":"The mechanisms, diagnosis, and management of severe asthma in adults","volume":"368","author":"Holgate","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2014.08.010_bib0015","series-title":"The global strategy for asthma management and prevention","author":"Global Initiative for Asthma (GINA)","year":"2012"},{"key":"10.1016\/j.imlet.2014.08.010_bib0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.imlet.2014.08.010_bib0025","first-page":"CD003559","article-title":"Anti-IgE for chronic asthma in adults and children","volume":"3","author":"Walker","year":"2004","journal-title":"CDS Rev"},{"key":"10.1016\/j.imlet.2014.08.010_bib0030","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1183\/09031936.02.00016502","article-title":"The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma","volume":"20","author":"Buhl","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.imlet.2014.08.010_bib0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1006304","article-title":"The path to personalized medicine","volume":"363","author":"Hamburg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.08.010_bib0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pupt.2012.09.005","article-title":"From \u201cblockbusters\u201d to \u201cbiosimilars\u201d: an opportunity for patients, medical specialists and health care providers","volume":"25","author":"Braido","year":"2012","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.imlet.2014.08.010_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.it.2012.02.003","article-title":"Trials and tribulations in identifying new biologic treatments for asthma","volume":"33","author":"Holgate","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0050","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2014.08.010_bib0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.imlet.2014.08.010_bib0060","first-page":"3","article-title":"Airway remodelling in asthma and novel therapy","volume":"31","author":"Manuyakorn","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0065","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaci.2007.01.055","article-title":"Specificity of basement membrane thickening in severe asthma","volume":"119","author":"Bourdin","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/039463201202500217","article-title":"Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients","volume":"25","author":"Riccio","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0075","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2005.06.011","article-title":"Differences in airway remodeling between subjects with severe and moderate asthma","volume":"116","author":"Pepe","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2014.08.010_bib0085","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1039\/c3mb70194h","article-title":"Trials and tribulations of \u2018omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine","volume":"9","author":"Wheelock","year":"2013","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.imlet.2014.08.010_bib0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/10890","article-title":"Direct analysis of protein complexes using mass spectrometry","volume":"17","author":"Link","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nmeth.1195","article-title":"A quantitative analysis software tool for mass spectrometry-based proteomics","volume":"5","author":"Park","year":"2008","journal-title":"Nat Methods"},{"key":"10.1016\/j.imlet.2014.08.010_bib0100","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2011-07-365510","article-title":"Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue","volume":"119","author":"Brambilla","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2014.08.010_bib0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1095\/biolreprod.112.103887","article-title":"Developmental arrest and mouse antral not-surrounded nucleolus oocytes","volume":"88","author":"Monti","year":"2013","journal-title":"Biol Reprod"},{"key":"10.1016\/j.imlet.2014.08.010_bib0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1164\/rccm.200809-1522ST","article-title":"An official research policy statement of the American Thoracic Society\/European Respiratory Society: standards for quantitative assessment of lung structure","volume":"181","author":"Hsia","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.imlet.2014.08.010_bib0115","first-page":"934","article-title":"1,25-Dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages","volume":"30","author":"Villaggio","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jms.578","article-title":"Acid-labile surfactant improves in-sodium dodecyl sulfate polyacrylamide gel protein digestion for matrix-assisted laser desorption\/ionization mass spectrometric peptide mapping","volume":"39","author":"Nomura","year":"2004","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.imlet.2014.08.010_bib0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0076-6879(08)02206-4","article-title":"A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli","volume":"447","author":"Mauri","year":"2008","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4238\/vol7-2gmr426","article-title":"Identifying differences in protein expression levels by spectral counting and feature selection","volume":"7","author":"Carvalho","year":"2008","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.imlet.2014.08.010_bib0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/bib\/bbn005","article-title":"Approaches to dimensionality reduction in proteomic biomarker studies","volume":"9","author":"Hilario","year":"2008","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.imlet.2014.08.010_bib0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1145\/331499.331504","article-title":"Data clustering: a review","volume":"31","author":"Jain","year":"1999","journal-title":"ACM Comput Surv"},{"key":"10.1016\/j.imlet.2014.08.010_bib0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/MB:31:1:055","article-title":"Data clustering in life sciences","volume":"31","author":"Zhao","year":"2005","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/bioinformatics\/btl604","article-title":"BioNetBuilder: automatic integration of biological networks","volume":"23","author":"Avila-Campillo","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.imlet.2014.08.010_bib0155","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.imlet.2014.08.010_bib0160","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/bioinformatics\/bti551","article-title":"BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks","volume":"21","author":"Maere","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.imlet.2014.08.010_bib0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.imlet.2014.08.010_bib0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4049\/jimmunol.161.1.385","article-title":"Galectin-3 down-regulates IL-5 gene expression on different cell types","volume":"161","author":"Cortegano","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0175","first-page":"823279","article-title":"Gene expression profiling in lungs of chronic asthmatic mice treated with galectin-3: downregulation of inflammatory and regulatory genes","author":"L\u00f3pez","year":"2011","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.imlet.2014.08.010_bib0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2249.2012.04665.x","article-title":"Reduced expression of galectin-1 and galectin-9 by leucocytes in asthma patients","volume":"170","author":"Sanchez-Cuellar","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0185","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.1000039","article-title":"Allergen-induced airway remodeling is impaired in galectin-3-deficient mice","volume":"185","author":"Ge","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2014.08.010_bib0195","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature11546","article-title":"Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor","volume":"491","author":"Kim","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2014.08.010_bib0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2014.08.010_bib0205","doi-asserted-by":"crossref","first-page":"e56015","DOI":"10.1371\/journal.pone.0056015","article-title":"The role of IgE-receptors in IgE-dependent airway smooth muscle cell remodelling","volume":"8","author":"Roth","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.imlet.2014.08.010_bib0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2047-1440-1-9","article-title":"Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients","volume":"1","author":"Loftheim","year":"2012","journal-title":"Transplant Res"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:34:03Z","timestamp":1759044843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247814001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0165247814001801"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2014.08.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}